NASDAQ OMX

Favro Introduces Its Online Collaboration Platform to The Enterprise

24.10.2016 16:03 | NASDAQ OMX

Del

UPPSALA, Sweden, 2016-10-24 16:03 CEST (GLOBE NEWSWIRE) --

Favro, an online planning and collaboration tool, is launching its enterprise platform bringing agile management practices to global, large-scale workforces. Favro Enterprise comes from the Swedish award-winning project management software firm Hansoft. Team Hansoft has spent the past decade designing efficient and innovative tools to enhance agile project management and team collaboration in organizations developing software and hardware products.

“We wanted to bring agile to all. Not just for product developers but also teams doing sales, marketing, executive management, everyone in the organization. With Favro we built a planning and collaboration tool as easy to use as the simplest tools in the market, yet powerful enough to to tackle today’s enterprise workplace complexities,” said Patric Palm, CEO and co-founder. “Enterprises can no longer afford to make a trade-off between ease of use for everyone and enterprise-scale collaboration abilities. With Favro Enterprise, they can now have both.”

As teams in modern organizations become more and more autonomous, they also start choosing their own tools. This has the side-effect of creating silos within organizations and making cross-team collaboration more difficult. Favro Enterprise, accessible both online and through its mobile app, is designed for large-scale organizations to easily fill collaboration gaps allowing teams to better adapt to changing environments and work towards bigger goals together. With Favro, enterprises can migrate to a cloud based tool liked by teams and CFOs alike, while maintaining the right level of IT governance, compliance, and security.

Favro Enterprise also allows organizations to add features and workflow power-apps where and when they need them. Teams can integrate Favro with other apps they currently use including services from Google, Slack, and GitHub to automate and stay synchronized. Teams can also use webhooks and the REST API to connect Favro to even more data sources, ensuring work is always relevant and up to date.

Leading up to the public release of Favro Enterprise, the free and standard plans have been in soft-launch. Early customers have been able to experience Favro Enterprise capabilities and the tool’s usability across their organizations. Unity Technologies, the leading global game industry software, is one. 

“Our teams are creative and passionate in everything they do. That’s our culture worldwide. They work autonomously and pick the tools they think best will help them reach their goals. I’m impressed how rapidly Favro has gained popularity and is spreading from team to team at Unity,” said David Helgason, Founder of Unity Technologies.

“We really like using Favro. It’s very intuitive and easy to use, yet it has the power our developers need to maintain a project’s overview both on an individual, team, and department level at all times. This creates a well working alignment among global teams while also promoting team and individual empowerment,” said Ulas Karademir, Director of Core Technology and Operations at Unity Technologies. “Favro integrates well with other tools and the extra power-apps gives us the management capabilities we need to be efficient leaders and team players. It makes project management fun for us at Unity.”

About Favro

Favro is an online planning and collaboration tool built to empower teams and leaders who embrace change and develop organically. Favro’s intuitive and adaptable interface makes it easy to collaborate with any team member in or outside your organization on just about any project. To learn more about Favro visit https://favro.com.

About Team Hansoft

From offices in Sweden, USA, Ukraine, Vietnam and Japan, Hansoft supports global companies as they migrate to become Agile Enterprises. Team Hansoft’s product portfolio consists of Favro, offered in the cloud, and the on-premise product Hansoft A3. Hansoft A3 has been in the market for a decade and is continuously updated with bi-weekly releases. Hansoft A3 is used for team collaboration, program and portfolio management in Agile development of products and services, used in industries such as Electronics, Aerospace, Defence, Game Development, and Telecom. Members at all levels in these organizations use Hansoft A3 for Scrum and tailored agile methods, Kanban, collaborative Gantt scheduling, defect tracking, real-time reporting, workload and portfolio analysis among other things. To learn more about Team Hansoft, visithttps://www.favro.com/company. To learn more about Hansoft A3, visit https://hansoft.com.

         Contact:
         Tyler Balkin
         tyler.balkin@walkersands.com
         312-561-2482

Om NASDAQ OMX

NASDAQ OMX
NASDAQ OMX
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra NASDAQ OMX

Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra NASDAQ OMX

Nasdaq Welcomes I-AM Capital Acquisition Company (Nasdaq: IAMXU) to The Nasdaq Stock Market17.8.2017 18:50Pressemelding

NEW YORK, Aug. 17, 2017 (GLOBE NEWSWIRE) -- I-AM Capital Acquisition Company (Nasdaq:IAMXU), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, celebrated its initial public offering (IPO) on The Nasdaq Stock Market.  I-AM Capital's founders, Chief Executive Officer F. Jacob Cherian and Chief Financial Officer Suhel Kanuga, have been focused on investing into India over the last decade, with the distinction of completing the first listed-SPAC investment in India. "Through our keen focus and unique accomplishments in India over the last decade, we have seen our investment thesis bear fruit: India's prominence and rise on the world stage, its distinction as being one of the fastest growing major economies of the world, and its strong vibrant consumer demographics. We believe these factors are aligning well now,

Tetraphase Pharmaceuticals Announces Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency17.8.2017 14:30Pressemelding

WATERTOWN, Mass., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- resistant (MDR) infections, today announced that the Marketing Authorization Application (MAA) for IV eravacycline for the treatment of complicated intra-abdominal infections (cIAI) has been submitted and was validated by the European Medicines Agency (EMA). Eravacycline is a novel, fully-synthetic fluorocycline antibiotic being developed for the treatment of serious infections, including those caused by multidrug-resistant (MDR) pathogens. The MAA filing is based on data from the phase 3 IGNITE1 clinical trial in which eravacycline was well tolerated and demonstrated statistical non-inferiority to ertapenem using the primary endpoint of clinical response at the test-of-cure (TOC) visit. "The MAA filing represents a significant milestone for Tetraphase as it is our

RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules17.8.2017 13:00Pressemelding

RedHill was granted the exclusive rights to promote Esomeprazole Strontium Delayed-Release (DR) Capsules to gastroenterologists in certain U.S. territories Esomeprazole Strontium DR Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI), indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal (GI) conditions   RedHill expects to initiate the U.S. promotion of Esomeprazole Strontium  DR Capsules 49.3 mg  in the coming weeks   Esomeprazole Strontium  DR Capsules 49.3 mg  will be the third commercial GI product to be promoted by RedHill in the U.S.    RedHill's GI-focused sales force currently promotes two GI s

Brand Industrial Services Announces Agreement to Acquire Venko Groep BV16.8.2017 19:40Pressemelding

Complementary core strengths provide broader range of services for customers KENNESAW, GA, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Brand Industrial Services, known as BrandSafway, has signed an agreement to acquire Venko Groep BV, a portfolio company of Mentha Capital. Venko will become a part of the Brand Energy & Infrastructure Services (Brand) group. "We are very pleased to announce the agreement with Venko," said Bill Hayes, President and CEO of BrandSafway. "Our combined customers in Europe will benefit from a broader range of solutions and greater depth of expertise in access, insulation and coatings. Bringing Venko's highly specialized knowledge in coatings to BrandSafway will provide the expertise we need to expand our services in the offshore market worldwide." Based in the Netherlands, with a focus on operations in the North Sea area, Venko is a leading offshore and onshore coatings maintenance provid

Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome Type A16.8.2017 15:38Pressemelding

NEW YORK and CLEVELAND, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, today announced the pivotal expansion of its gene therapy clinical trials for patients with MPS IIIA in the USA, Europe and Australia. "We have completed the necessary regulatory and ethical committee approvals and site initiations in Europe and Australia in order to accelerate enrollment," stated Juan Ruiz, M.D., Ph.D., Abeona's Chief Medical Officer. "We remain very encouraged by the improvements observed in clinically relevant biomarkers post-dosing of ABO-102, including durable reductions in heparan sulfate measured in the CNS, reduction of organ disease pathology, and signals of CNS improvement or stabilization at one-year follow-up in Cohort 1 subjects, and look forward to providing a more fulsome clinical update at important clinical

CallidusCloud Wins Eight Gold Stevies® in the 2017 International Business Awards16.8.2017 14:00Pressemelding

CallidusCloud Lead to Money suite recognized as Best B2B New Product of the Year. LeadRocket voted Best New Product or Service of the Year in the Software - Lead Generation Solution category. DUBLIN, Calif., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based sales, marketing, learning, and customer experience solutions, announced today that it was named the winner of eight Gold Stevie® awards in the 2017 International Business Awards. "The eight Stevie® awards earned highlight CallidusCloud's momentum, commitment to excellence, passion for innovation and customer orientation," said Leslie Stretch, president and CEO of CallidusCloud. "They also recognize the benefits that the Lead to Money suite, honored as the Best New Product in Business-to-Business, accrues to its customers in terms of enabling faster, bigger, and more profitable sales." CallidusCloud's Go

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom